How mRNA is powering a personalised vaccine revolution

The COVID-19 pandemic introduced mRNA-based vaccines to the forefront, however the breadth of purposes for this expertise is way wider. As of 25 June 2024, 70 trials had been recruiting sufferers for mRNA-based vaccines, in line with the web site ClinicalTrials.gov. These mRNA-based vaccines ship the blueprint of a protein, equivalent to an antigen, for the physique’s cells to provide, which prompts the affected person’s immune system in opposition to a particular illness.

doi: https://doi.org/10.1038/d41591-024-00052-y